Stay updated on SubQ Lirentelimab Bioavailability in Healthy Adults Clinical Trial
Sign up to get notified when there's something new on the SubQ Lirentelimab Bioavailability in Healthy Adults Clinical Trial page.

Latest updates to the SubQ Lirentelimab Bioavailability in Healthy Adults Clinical Trial page
- Check4 days agoChange DetectedThe page revision annotation was updated from v3.3.3 to v3.3.4. This is a minor metadata update.SummaryDifference0.1%

- Check11 days agoNo Change Detected
- Check18 days agoNo Change Detected
- Check26 days agoChange DetectedAdded a Locations section with Edgewater, Florida as the study site and updated the page to revision v3.3.3; the HHS Vulnerability Disclosure link was removed.SummaryDifference0.2%

- Check54 days agoChange DetectedA new Revision: v3.3.2 appears, replacing the previous Revision: v3.2.0. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check61 days agoChange DetectedRemoval of a government funding status notice; the study details and other content remain unchanged.SummaryDifference0.4%

- Check76 days agoChange DetectedThis update appears limited to cosmetic UI/layout adjustments with no changes to core study information (design, eligibility criteria, endpoints). To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.5%

- Check104 days agoChange DetectedThe page now shows a new version (v3.2.0) and a government-operating-status notice, while removing the previous version reference (v3.1.0).SummaryDifference4%

Stay in the know with updates to SubQ Lirentelimab Bioavailability in Healthy Adults Clinical Trial
Enter your email address, and we'll notify you when there's something new on the SubQ Lirentelimab Bioavailability in Healthy Adults Clinical Trial page.